Key facts
- This page summarizes Troyen A. Brennan's Form 4 filing for CVS HEALTH Corp (CVS).
- 2 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 05 Apr 2022, 19:36.
Troyen A. Brennan - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- EVP and Chief Medical Officer
- Issuer ticker
- CVS
- Reported as of
- 01 Apr 2022
- Net transaction value
- -$8,101,252
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2022, 19:36:21 UTC
- Prior SEC filing
- 23 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Troyen Brennan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Troyen A. Brennan filed Form 4 for CVS HEALTH Corp (CVS) on 05 Apr 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: -$8,101,252.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Tax liability
- Transaction value
- $7,880,976
- Shares
- -77,960
- Change %
- -25%
- Price
- $101.09
- Shares after
- 234,855
- Date
- 01 Apr 2022
- Ownership
- Direct
- Footnotes
- F1
CVS
transaction
Common Stock
Tax liability
- Transaction value
- $220,275
- Shares
- -2,179
- Change %
- -0.93%
- Price
- $101.09
- Shares after
- 232,676
- Date
- 03 Apr 2022
- Ownership
- Direct
- Footnotes
- F2
CVS
holding
Common Stock (restricted)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,805
- Date
- 01 Apr 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 53,772
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 53,772
- Exercise price
- $104.82
- Footnotes
- F3
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,134
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,134
- Exercise price
- $78.05
- Footnotes
- F4
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,894
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,894
- Exercise price
- $62.21
- Footnotes
- F5
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 80,803
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,803
- Exercise price
- $54.19
- Footnotes
- F6
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 84,478
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 84,478
- Exercise price
- $58.34
- Footnotes
- F7, F8
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 99,344
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 99,344
- Exercise price
- $74.30
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022.
Footnote F2
Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan.
Footnote F3
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Footnote F4
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Footnote F5
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Footnote F6
Option became exercisable in four equal annual installments, commencing 4/1/2020.
Footnote F7
The number of shares subject to the option were calculated using a 30-day average price.
Footnote F8
Options became exercisable in four equal annual installments, commencing 4/1/2021.
Footnote F9
Option becomes exercisable in four equal annual installments, commencing 4/1/2022.